Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 02, 2022

BUY
$0.13 - $12.4 $39 - $3,720
300 Added 25.0%
1,500 $1,000
Q2 2022

Aug 12, 2022

BUY
$1.11 - $3.46 $111 - $346
100 Added 9.09%
1,200 $1,000
Q1 2022

May 13, 2022

BUY
$1.78 - $8.5 $712 - $3,400
400 Added 57.14%
1,100 $4,000
Q4 2021

Feb 14, 2022

BUY
$7.3 - $11.24 $5,110 - $7,868
700 New
700 $5,000

Others Institutions Holding SABS

About SAB Biotherapeutics, Inc.


  • Ticker SABS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,030,900
  • Market Cap $184M
  • Description
  • SAB Biotherapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the development of immunotherapies based on human antibodies. It has applied advanced genetic engineering and antibody science to develop transchromosomic bovine herds that produce fully human antibodies targeted at specific diseases, including infectious diseases ...
More about SABS
Track This Portfolio

Track Rockefeller Capital Management L.P. Portfolio

Follow Rockefeller Capital Management L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rockefeller Capital Management L.P., based on Form 13F filings with the SEC.

News

Stay updated on Rockefeller Capital Management L.P. with notifications on news.